IQVIA (IQV) Competitors

Bruker (NASDAQ:BRKR) and IQVIA (NYSE:IQV) are related companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

Does the media refer more to BRKR or IQV?

In the previous week, IQVIA had 15 more articles in the media than Bruker. MarketBeat recorded 21 mentions for IQVIA and 6 mentions for Bruker. Bruker's average media sentiment score of 1.14 beat IQVIA's score of 0.97 indicating that Bruker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IQVIA	12 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, BRKR or IQV?

Bruker has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in BRKR or IQV?

79.5% of Bruker shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 27.3% of Bruker shares are held by insiders. Comparatively, 1.6% of IQVIA shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Do analysts recommend BRKR or IQV?

Bruker presently has a consensus target price of $52.89, suggesting a potential upside of 20.78%. IQVIA has a consensus target price of $222.45, suggesting a potential upside of 36.70%. Given IQVIA's stronger consensus rating and higher probable upside, analysts clearly believe IQVIA is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40
IQVIA	0 Sell rating(s)	7 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.75

Is BRKR or IQV more profitable?

IQVIA has a net margin of 8.61% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 29.16% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	2.31%	19.47%	5.95%
IQVIA	8.61%	29.16%	6.96%

Which has preferable valuation & earnings, BRKR or IQV?

IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.37B	1.97	$113.10M	$0.52	84.21
IQVIA	$15.41B	1.83	$1.37B	$7.34	22.17

Summary

IQVIA beats Bruker on 13 of the 17 factors compared between the two stocks.